Exploring binding and effector functions of natural human antibodies using synthetic immunomodulators.
The ability to profile the prevalence and functional activity of endogenous antibodies is of vast clinical and diagnostic importance. Serum antibodies are an important class of biomarkers and are also crucial elements of immune responses elicited by natural disease-causing agents as well as vaccines. In particular, materials for manipulating and/or enhancing immune responses toward disease-causing cells or viruses have exhibited significant promise for therapeutic applications. Antibody-recruiting molecules (ARMs), bifunctional organic molecules that redirect endogenous antibodies to pathological targets, thereby increasing their recognition and clearance by the immune system, have proven particularly interesting. Notably, although ARMs capable of hijacking antibodies against oligosaccharides and electron-poor aromatics have proven efficacious, systematic comparisons of the prevalence and effectiveness of natural anti-hapten antibody populations have not appeared in the literature. Herein we report head-to-head comparisons of three chemically simple antigens, which are known ligands for endogenous antibodies. Thus, we have chemically synthesized bifunctional molecules containing 2,4-dinitrophenyl (DNP), phosphorylcholine (PC), and rhamnose. We have then used a combination of ELISA, flow cytometry, and cell-viability assays to compare these antigens in terms of their abilities both to recruit natural antibody from human serum and also to direct serum-dependent cytotoxicity against target cells. These studies have revealed rhamnose to be the most efficacious of the synthetic antigens examined. Furthermore, analysis of 122 individual serum samples has afforded comprehensive insights into population-wide prevalence and isotype distributions of distinct anti-hapten antibody populations. In addition to providing a general platform for comparing and studying anti-hapten antibodies, these studies serve as a useful starting point for the optimization of antibody-recruiting molecules and other synthetic strategies for modulating human immunity.
Carlson School of Chemistry and Biochemistry, Clark University , 950 Main Street, Worcester, Massachusetts 01610, United States.
Charles E
CE
Jakobsche
Christopher G
CG
Parker
Ran N
RN
Tao
Mariya D
MD
Kolesnikova
Eugene F
EF
Douglass
David A
DA
Spiegel
D000818:Animals; D000906:Antibodies / Q000737:chemistry / Q000378:metabolism*; D000941:Antigens / Q000378:metabolism*; D001667:Binding, Competitive; D016466:CHO Cells; D002470:Cell Survival; D003412:Cricetulus; D004345:Drug Industry; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D007155:Immunologic Factors / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism; D015394:Molecular Structure; D008970:Molecular Weight; D010648:Phenylacetates / Q000378:metabolism; D010767:Phosphorylcholine / Q000378:metabolism; D011485:Protein Binding; D012210:Rhamnose / Q000378:metabolism
D000906:Antibodies; D000941:Antigens; D007155:Immunologic Factors; D010648:Phenylacetates; D010767:Phosphorylcholine; C026869:2,4-dinitrophenylacetic acid; D012210:Rhamnose